CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) revenue & profit
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL): revenue $4B, net income -$144.3M in 2025; latest quarter -2.7% year over year. From SEC filings.
$4BRevenue 2025
TickerCRL (NYSE)
IndustryHealthcare · Services-Commercial Physical & Biological Research
Revenue 2025$4B
Net income 2025-$144.3M
Net margin-3.6%
Annual revenue growth-0.9%
Latest quarter (2026 Q2) · Revenue$1B
vs. same quarter last year-2.7%
Latest quarter · Net income-$1.5M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $4B | $486.2M | |
| 2023 | $4.1B | $474.6M | |
| 2024 | $4B | $22.2M | |
| 2025 | $4B | -$144.3M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.